1. Introduction {#S1}
===============

Exposure to prenatal inflammation is associated with adverse long-term neurobehavioral outcomes for exposed infants, including learning and sensory-motor deficits, epilepsy, schizophrenia and autism spectrum disorder [@R3]; [@R11]; [@R27]; [@R32]; [@R49]; [@R58]; [@R67]; [@R68]. One of the most common clinical scenarios by which a fetus is exposed to inflammation is in the setting of preterm birth which is associated with local infection or inflammation in the uterus. It has been suggested that intrauterine inflammation disrupts a critical window of brain development, leading to an array of postnatal deficits [@R20]. Animal studies support a role for altered glial development ("white matter damage") as well as neuronal injury as a proposed mechanism by which exposure to intrauterine inflammation leads to adverse neurological outcomes [@R10]; [@R12]; [@R44]. However, the effect of prenatal inflammation on distinct brain areas with well characterized behavioral functions still remains largely unknown.

The role of the hippocampus in learning and memory has been well characterized [@R25]; [@R35]; [@R85] and is thought to rely on continuing neuronal production which takes place in the hippocampal subgranular zone (SGZ) of the postnatal brain [@R2]; [@R62]; [@R71]; [@R71]. The SGZ supports neural stem and progenitor cells (NPCs) which undergo repeated mitotic divisions [@R57] producing differentiating cellular progeny which, upon completion of differentiation and maturation stages, become fully functional dentate granule neurons that are indiscernible morphologically and physiologically from granule cells born *in utero* [@R4]; [@R80]; [@R92]; [@R94]. In the process of maturation, the majority of newborn cells navigate radially within the granule cell layer (GCL); however, some of these cells fail to retain their normal position and migrate further into the hilar area [@R46]. These so called hilar ectopic granule cells (hEGCs) develop abnormal synaptic connectivity and show altered morphological and electrophysiological properties compared to the granule cells that reside within the GCL [@R87]; [@R86]; [@R100]. An unusually high presence of hEGCs has been documented in animal models of epilepsy and is thought to contribute to the development of this disorder [@R15]; [@R46].

Hippocampal neurogenesis is a highly dynamic process known to be regulated by various environmental, physiological and pathological stimuli [@R2]. In particular, it has been shown that systemic maternal inflammation during pregnancy can negatively affect postnatal neurogenesis in the hippocampal SGZ [@R42]. However, the role of intrauterine inflammation, as might occur in spontaneous preterm birth, on hippocampal neurogenesis has not been investigated in much detail [@R52]. We hypothesize that exposure to intrauterine inflammation during a critical period of brain development will specifically alter hippocampal neurogenesis in the postnatal brain. In addition, microglial and astroglial cell populations have been shown to play a role in modulating neuronal production in the adult brain. In particular, microglia, which represent resident brain macrophages [@R60]; [@R93], are responsible for reducing the rate of postnatal neurogenesis following both systemic [@R72] and local (within the brain) [@R26] inflammatory stimuli. Similarly, astrocyte function is also involved in the regulation of hippocampal neurogenesis under both normal [@R6]; [@R59] and inflammatory conditions Vallieres et al., 2002. Using our previously established model of inflammation-induced fetal brain injury [@R13],[@R14]; [@R29], this study sought to address the effect of *in utero* inflammation on early postnatal neurogenesis and granule cell migration in the hippocampal SGZ as well as to examine possible alterations in microglial and astroglial cell populations.

2. Results {#S2}
==========

2.1. Exposure to intrauterine inflammation reduces early postnatal neurogenesis {#S3}
-------------------------------------------------------------------------------

Alterations in hippocampal neurogenesis were determined by labeling mitotically active NPCs with BrdU on postnatal days 7 and 8 and quantifying their neuronal progeny a week later, on P14 ([Fig. 1A and B](#F1){ref-type="fig"}). Dual labeling with BrdU and the neuron-specific marker NeuN identified newly generated granule cells within the upper and lower blades of the dentate cell body layer ([Fig. 1B](#F1){ref-type="fig"}). A significant reduction in the density of BrdU-labeled cells was detected in pups exposed to intrauterine inflammation as compared to control saline-injected animals ([Fig. 1C](#F1){ref-type="fig"}, p = 0.023).

2.2. Intrauterine inflammation leads to decreased neuronal density in the dentate gyrus at P28 {#S4}
----------------------------------------------------------------------------------------------

Since we observed inflammation-induced decline in hippocampal neurogenesis, granule neuron density and GCL thickness were assessed at P14 and P28 using a neuronal marker Prox1. While granule cell density was not different between control and experimental groups at P14, it was reduced at P28 after exposure to inflammation ([Fig. 2A](#F2){ref-type="fig"}, p = 0.002). GCL thickness was not affected at either time point ([Fig. 2B](#F2){ref-type="fig"}).

2.3. Exposure to intrauterine inflammation generates ectopic granule cells {#S5}
--------------------------------------------------------------------------

Prox1 labeled granule cells in the hilus of inflammation-exposed pups and saline-exposed pups were compared to ascertain if any granule cells were migrating improperly ([Fig. 2C](#F2){ref-type="fig"}). Following exposure to intrauterine inflammation, the number of hEGCs was significantly increased at P14 (p = 0.023) ([Fig. 2C and D](#F2){ref-type="fig"}). This effect was not apparent at P28 ([Fig. 2C](#F2){ref-type="fig"}).

2.4. Intrauterine inflammation has no effect on total number and division rate of neural stem and progenitor cells at P14 and P28 {#S6}
---------------------------------------------------------------------------------------------------------------------------------

The total number of hippocampal stem and progenitor cells was measured by counting nestin-positive cells in the SGZ of inflammation-exposed and control animals ([Fig. 3A](#F3){ref-type="fig"}). The density of NPCs was not altered between exposed and unexposed pups at either P14 or P28 ([Fig. 3B](#F3){ref-type="fig"}). Additionally, exposure to prenatal inflammation did not affect the number of mitotically active cells within the SGZ ([Fig. 3C and D](#F3){ref-type="fig"}). Hence, there were no differences in Ki67-positive cell densities present at either time point.

2.5. Intrauterine inflammation has no effect on postnatal apoptosis in the dentate gyrus {#S7}
----------------------------------------------------------------------------------------

Apoptotic cells measured by labeling with an antibody against Cleaved Caspase 3 ([Fig. 4A](#F4){ref-type="fig"}) were sparse in both treatment groups and their presence did not change in response to intrauterine inflammation at either time point ([Fig. 4B](#F4){ref-type="fig"}).

2.6. Intrauterine inflammation has no effect on hippocampal microglia and astroglia densities {#S8}
---------------------------------------------------------------------------------------------

Microglial density was quantified in various regions of the hippocampus, including hilus, dentate gyrus (DG) and Cornu ammonis 1--3 (CA1-3), using antibodies against microglial marker Iba1 ([Fig. 5A](#F5){ref-type="fig"}). Our data show that the number of microglial cells did not vary by exposure at P14 ([Fig. 5B](#F5){ref-type="fig"}) or P28 (not shown).

The astrocyte specific marker Glial Fibrillary Acidic Protein (GFAP) was used for measuring astroglial density in the hippocampus ([Fig. 6A](#F6){ref-type="fig"}). Similar to findings with microglia, exposure to intrauterine inflammation did not alter the number of astrocytes in the various regions of the hippocampus in any of the regions analyzed at P14 ([Fig. 6B](#F6){ref-type="fig"}) or P28 (not shown).

3. Discussion {#S9}
=============

Exposure to prenatal inflammation has been strongly associated with a spectrum of adverse neurobehavioral outcomes in exposed offspring, including motor-sensory deficits, delayed learning and neurological disease, such as schizophrenia, autism spectrum disorder and epilepsy [@R5]; [@R17]; [@R33]; [@R43]; [@R50]; [@R53], [@R54]; [@R61]; [@R88]. However, there is still a paucity of data on how an inflammatory environment *in utero* leads to fetal brain injury, causing neurobehavioral abnormalities in childhood and adulthood. In this study, we demonstrate that in addition to previously reported white matter damage and neuronal injury [@R13],[@R14]; [@R29]; [@R76], early exposure to intrauterine inflammation results in a reduced rate of neurogenesis in the hippocampal SGZ and the accumulation of ectopic dentate granule cells known to be implicated in synaptic malfunction and increased neuronal excitability. As altered hippocampal function is associated with many neurological deficits, these findings provide a new mechanism by which exposure to intrauterine inflammation may lead to long term adverse outcomes.

The finding of decreased neuronal production in the hippocampal SGZ in response to intrauterine inflammation is consistent with a number of previous studies made in rodent model systems which reveal a reduction in postnatal neurogenesis following systemic inflammatory insults, including those evoked by *E. coli* LPS [@R18]; [@R39]; [@R40], [@R41]; [@R65]; [@R73]. In contrast, a local *E. coli* administration in pregnant rats, which was shown to induce an inflammatory response in the uterus, increased NPC divisions between P3 and P28 but did not change neuronal and astroglial production measured at P28 [@R52]. The inconsistency between the results of this study and our data can be attributed to multiple differences in experimental design including the application of different rodent models (rat *vs* mouse), infectious agents (*E. coli vs* LPS), routes of *E. coli*/LPS administration (endocervical *vs* intrauterine), BrdU labeling regimens (50 μg/kg BrdU for three or seven consecutive days at various time points *vs* two 75 μg/kg BrdU injections at P7 and P8) and time points of tissue collection and analysis. Thus, our data contribute to the accumulating evidence showing a negative effect of prenatal inflammation on hippocampal neurogenesis during early postnatal period. Importantly, this finding was obtained by applying a more clinically relevant route of evoking prenatal inflammation, intrauterine inflammation using LPS, as opposed to a systemic infectious or inflammatory exposure.

The observed reduction in novel neuronal production and total granule cell density can be caused by decreased abundance of cycling NPCs and/or increased apoptosis among differentiating granule cells [@R36]; [@R89]. As our measurements showed no change in the numbers of total and dividing NPCs or the rate of apoptosis at both examined time points (P14 and P28), it is plausible that prenatal exposure to intrauterine inflammation exerts a negative effect on hippocampal neurogenesis by influencing the rate of NPC amplification earlier during postnatal development, between P7 and P14.

Alterations in neuronal production in the adult brain have been associated with significant behavioral changes. For example, in a mouse model, genetic or pharmacological ablation of hippocampal neurogenesis impairs animal performance in certain hippocampus-dependent learning and memory tasks [@R23]; [@R42]; [@R71]. In addition, a decrease in neuronal production in response to systemic inflammation is known to be associated with increased anxiety [@R8]; [@R83] and depression-like behaviors [@R47]; [@R65]; [@R90]; Vollmayer et al., 2007. Reduced NPC proliferation has also been detected in the brains of schizophrenic patients [@R82]. On the contrary, reducing the neurogenesis rate in an animal model of status epilepticus appears to play a protective role as this manipulation decreases the frequency of acute seizures and prevents associated cognitive deficits [@R16]. It remains to be demonstrated how reduction in postnatal neuronal production in this model of intrauterine inflammation may lead to disruptions in behavioral function.

We also show for the first time that exposure to *in utero* inflammation is sufficient to cause an aberrant distribution of newly formed granule cells as manifested by the presence of hEGCs. Interestingly, while extra hEGCs are present in the hilus area at P14, they are no longer detectable at the later time point, P28, which suggests that the hippocampus may, at least temporarily, recover from the prenatal insult. Although the accumulation of hEGCs takes place during a limited developmental window, their presence may still adversely affect hippocampal function and behavioral performance which have been shown to be altered in response to intrauterine inflammation [@R56]; [@R66]. In particular, as shown in animal models of epilepsy, misplaced granule cells differ from other granule neurons in that they develop excessive excitatory innervation while being almost devoid of inhibitory inputs [@R79]; [@R86]; [@R87]; [@R100]. As a result, these cells demonstrate increased spontaneous activity [@R22]; [@R79] and frequent firing [@R86] as compared to normally situated granule neurons, which is thought to contribute to epileptogenesis [@R9]; [@R21]; [@R46]. Thus, the aberrant positioning of newly formed granule cells following exposure to prenatal inflammation may lead to the development of epilepsy-like symptoms and other behavioral abnormalities, such as certain memory deficits [@R75], later in life. It has also been shown that the accumulation of hEGCs can be caused by increased levels of certain growth factors, such as Insulin-like Growth Factor I (IGF-I), Vascular Endothelial Growth Factor (VEGF) and Brain-derived Neurotrophic Factor (BDNF), in the brain [@R86] and by inactivating the function of several genes, specifically, *Reelin* [@R91], *p35* [@R77], *protein L-isoaspartate (D-aspartate) O-methyltransferase* (*Pmct-1*) [@R31] and *Bcl-2-associated X protein* (*Bax*) [@R75]. Interestingly, intrauterine inflammation is known to lead to an elevated production of a number of neurotrophic factors in the fetal brain, including BDNF [@R29], while maternal immune activation induced systemically reduces hippocampal expression of the Reelin protein in the offspring [@R24]; [@R32]; [@R34]; [@R37]; [@R45]; [@R69], [@R70]; [@R81]. These data suggest that the displacement of granule cells in the dentate gyrus is a result of changes in neurotropic factors and/or modification of proteins involved in neurogenesis that can be directly induced by intrauterine inflammation.

Despite earlier reports showing microglial activation [@R12]; [@R19]; [@R95]; [@R55]; [@R63]; [@R66]; [@R84]; [@R98]; [@R101], astrogliosis [@R29] and decreased neuronal survival [@R7]; [@R29]; [@R64]; [@R99] after exposure to intrauterine inflammation, our study did not reveal similar changes at the examined time points (P14 and P28). This difference between our results and previously obtained data may derive from several variables in experimental conditions that are shown to affect the cellular and behavioral outcomes of prenatal inflammation, including the type of animal model, dose of infectious agent and the developmental time point at which the inflammation is induced [@R1]; [@R69]. While microglial activation has been previously detected using the same mouse model of low dose LPS-induced inflammation (50 μg) as that utilized in our study, these results were achieved by administering LPS at a different time during fetal development Dada et al., 2014 and collecting brain samples at alternative time points [@R66]. In addition, in both of these studies, FACS technique was implemented allowing for a more precise measurement of the sizes of microglial population. Consistent with our findings of unaltered astroglial densities in saline and LPS treated hippocampi, another study found that the expression of a commonly used astrocytic marker GFAP was unaffected in P7 hippocampus after exposure to intrauterine inflammation [@R28]. This finding, however, does not exclude the possibility that microglial and astroglial cells undergo corresponding functional changes in response to *in utero* inflammation at the developmental time points other than those analyzed in our study.

In conclusion, we have shown that, in addition to our previous reports of neuronal injury during the time of immediate exposure to intrauterine inflammation [@R13],[@R14]; [@R30], [@R29]; [@R76], *in utero* inflammatory challenge results in decreased hippocampal neurogenesis and aberrant positioning of newly generated granule cells in the hippocampus during the early postnatal period (P7--P28). These findings suggest that postnatal changes in hippocampal neurogenesis may be mechanistically involved in neurobehavioral abnormalities observed in affected offspring [@R11]; [@R38]; [@R67]; [@R68]. Understanding the mechanisms by which exposure to intrauterine inflammation, which is a common event in human pregnancy, leads to adverse neurobehavioral outcomes for exposed offspring can open new avenues for future therapeutic strategies. Further work is needed to demonstrate what specific behavioral disruptions are associated with these observed changes in neuronal development and function to further advance the field and decrease morbidity from this common exposure.

4. Experimental procedure {#S10}
=========================

4.1. Mouse model of intrauterine inflammation {#S11}
---------------------------------------------

A previously described mouse model of intrauterine inflammation, which results in fetal and postnatal brain injury [@R13],[@R14]); [@R29]; [@R28]; [@R51] was utilized for these studies. For all experiments, CD-1, timed pregnant mice were purchased from Charles River Laboratories (Wilmington, MA). Animals were shipped 8--12 days after mating and allowed to acclimate in our facility for 3--7 days. A mini-laparotomy was performed under isoflurane anesthesia at gestational day 15 (E15) with normal gestation being 19--20 days. Briefly, the right uterus was exposed allowing visualization of the lowest two gestational sacs. Mice then received intrauterine injections of LPS from *Escherichia coli* (055:B5, Sigma, St Louis, MO, L2880, 50 μg/100 μl phosphate buffered saline/animal; LPS-treated group) or PBS (100 μl/animal; control, saline-treated group). Surgical incisions were closed using staples and dams were allowed to recover. Mice were provided food and water *ad libitum* and maintained on a 12:12 h light/dark cycle. Term delivering litters were culled to 5 pups/cage at P1-3 (P14: LPS, n = 10; saline, n = 8; P28: LPS n = 6; saline n = 6). All experiments were performed in accordance with the National Institute of Health Guidelines on Laboratory Animals with approval from the University of Pennsylvania's Animal Care and Use Committee (protocol number 804658).

4.2. BrdU administration, neonatal brain perfusion and tissue collection {#S12}
------------------------------------------------------------------------

The thymidine analogue bromodeoxyuridine (BrdU) (Sigma LifeSciences, B5002-500 mg; Sigma-Aldrich, St Louis, MO) was dissolved in phosphate-buffered saline (PBS) and injected subcutaneously to all pups at P7 and P8 (75 mg/kg). Pups were anesthetized with a Ketamine/Xylazine cocktail (200 mg/kg; 10 mg/kg, i.p. respectively) and transcardially perfused with 10 U/mL heparin, 2.5% paraformaldehyde, and 4% sucrose in PBS, pH 7.4 at P14 (n = 18). Brains were removed, fixed overnight in the same solution, cryoprotected in 30% sucrose (in PBS), and flash frozen in isopentane at −25 °C. Brains were sectioned coronally at 50 μm, mounted to gelatin-coated slides (2--3 sections/slide), and stored at −80 °C.

4.3. Immunohistochemistry {#S13}
-------------------------

Slide-mounted brain sections from dorsal hippocampus were processed for histology. Hippocampal sections were identified based on general morphological features of the area [@R78] and immunostained with antibodies against the following molecular markers: a DNA intercalating agent, BrdU (sheep anti-BrdU, 1:200; GeneTex), a marker of microglial cells Iba1 (rabbit anti-Iba1, 1:1000; Wako), a marker specific for dentate granule neurons and late neuronal progenitor cells, Prox1 (rabbit anti-Prox1, 1:500; Millipore), an apoptotic cell marker, Cleaved Caspase 3 (rabbit anti-cleaved caspase 3, 1:200; Cell Signaling), a marker of mitotic cells, Ki67 (rabbit anti-Ki67, 1:100; Abcam), an astroglial cell marker, GFAP (goat anti-GFAP, 1:300; Abcam), a neuronal cell marker, NeuN (mouse anti-NeuN, 1:300; Millipore), and a marker of neural stem and progenitor cells, Nestin (mouse anti-Nestin, 1:200; Abcam). Secondary labeling was performed with AlexaFluor 488 donkey anti-rabbit (Abcam), AlexaFluor 647 donkey anti-sheep (Abcam), AlexaFluor 488 donkey anti-mouse (Life Technologies), AlexaFluor 568 donkey anti-goat (Life Technologies), and AlexaFluor 568 donkey anti-mouse (Life Technologies). Brain sections were dehydrated in alcohol, cleared in xylenes, and coverslips were affixed with mounting media (Krystalon; Harleco).

4.4. Confocal microscopy and histological analyses {#S14}
--------------------------------------------------

Images were collected from a Zeiss LSM 710 confocal system set up on an AxioObserver inverted microscope and a Leica TCS SP8 confocal system set up on a DMI 6000 inverted microscope. Dorsal hippocampal sections (\~2 mm posterior to bregma; Paxinos and Franklin, 2001) were imaged by investigators blind to treatment group. All images were imported into ImageJ software for quantification.

The rate of postnatal neurogenesis was determined by analyzing confocal image stacks made from coronal brain slices immunostained with antibodies against BrdU and Ki67 protein. Each three-dimensional z-stack contained 10 images collected at 1 μm increments. For P7-P14 neurogenesis, mature neurons labeled with BrdU were imaged from the midpoint of the upper and lower blades (field size 420 × 420 μm) of the dentate cell body layer along the length of the SGZ. For P14 and P28 neurogenesis, Ki67 expressing neural progenitor cells were imaged from the upper and lower blades (field size 420 × 420 μm) of the SGZ of the DG. Ki67-expressing cells were counted if their cell bodies were proximal (\<30 μm) to the SGZ and exhibited a characteristic granule cell morphology (round shape, \~10 μm in cell body diameter). Neurons meeting the selection criterion were scored in three dimensional Z-stacks if their cell body came into focus when focusing from the surface of the tissue to the bottom [@R48]. The length of the SGZ was measured for each dentate blade using Fiji software and the sum of the length of both blades was used to normalize cell counts. For simplicity and to avoid confusion with area counts neuronal cell densities are presented as cell number per 100 μm of the SGZ instead of cell number per SGZ length multiplied by the depth of an image Z-stack.

Granule cell density and the thickness of the granule cell layer were determined by analyzing confocal images of Prox1 labeling. Counting frames (100 × 25 μm) were positioned at the midpoints of the upper and lower dentate blades in one hemisphere for each animal. Cell bodies that crossed the upper or right frame boundaries were included, and excluded if they crossed the lower or left frame boundaries. Granule cell density is presented as granule cells per square micrometer of tissue and granule cell thickness is shown in micrometers.

Hilar ectopic granule cell density was determined by analyzing confocal image stacks of Prox1 labeling. Images were collected at 1 μm increments through 10 μm of tissue to create three-dimensional confocal z-stacks. Granule cells were scored as ectopic if their cell bodies were at least 20 μm from the granule cell/hilar border and came into focus when focusing from the surface of the tissue to the bottom. The hilar areas within which ectopic granule cells were counted were outlined and measured using Fiji software. These areas were multiplied by the depth of a three-dimensional image Z-stack (10 × 1 μm = 10 μm) to calculate tissue volume. Obtained cell counts were divided by tissue volume to calculate cell density which is presented as cell number per cubic micrometer of tissue.

Neural stem and progenitor cell density was determined by analyzing confocal images of Nestin labeling. Nestin expressing NPCs were imaged from the upper and lower blades (field size 135 × 135 μm) of the SGZ of the DG. Images were collected at 1 μm increments through 10 μm of tissue to create three-dimensional confocal z-stacks. Nestin/DAPI expressing cells were counted if their cell bodies were proximal (\<30 μm) to the SGZ and their cell body came into focus when focusing from the surface of the tissue to the bottom. The length of the SGZ was measured for each dentate blade using Fiji software, and data are presented as cell number per 100 μm of the SGZ.

To assess apoptosis in the dentate granule cell layer, dentate gyri were screened under epifluorescent illumination for the presence of Cleaved Caspase-3 labeling. Manual cell counts were conducted throughout the SGZ and GCL in one hemisphere for each animal. Data are presented as the total number of Cleaved Caspase-3 expressing cells per GCL.

Microglia and astrocyte densities were determined by analyzing confocal image stacks of Iba1/DAPI and GFAP/DAPI labeling, respectively. Four hippocampal regions were assessed (DG, Hilus, CA1, CA2-3; field size 290 μm × 290 μm). Images were collected at 1 μm increments through 10 μm of tissue to create three-dimensional confocal z-stacks. Microglia and astrocytes were scored if their cell body came into focus when focusing from the surface of the tissue to the bottom. Respective hippocampal areas were outlined and measured using Fiji software. Tissue volume was calculated by multiplying area measurements by the depth of an image Z-stack (10 μm) and used for normalizing cell counts. Data are presented as cell number per cubic micrometer of tissue.

4.5. Statistics {#S15}
---------------

Statistical analyses were performed using SigmaStat software (version 12.5). T-tests were used for data that met assumptions of normality and equal variance, whereas Mann-Whitney U-tests were used when data violated one or both assumptions. P values \<0.05 were considered significant. Values are presented as mean s ± SEM.
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![Exposure to intrauterine inflammation reduces early postnatal neurogenesis. (A) Schematic of experimental design. Pregnant dams were given intrauterine injections of lipopolysaccharide (LPS) \[50 μg\] or saline on embryonic day 15. Pups delivered at term were culled \[5 pups/dam\] and given injections of bromodeoxyuridine \[BrdU, 75 mg/kg; s.c.\] at postnatal days 7 and 8 (P7--P8) to label actively proliferating cells. Mice were transcardially perfused with paraformaldehyde at postnatal day 14 (B). Confocal maximum projection images of BrdU (white) and Neuronal Nuclei (NeuN, red) co-labeling in the dentate gyrus of mice exposed to intrauterine saline or LPS and sacrificed at P14. Scale bar = 100 μm. (C) Quantification of BrdU/NeuN density in the granule cell layer at P14. LPS: n = 10; saline: n = 8. \*p\<0.05. Data represent the mean ± SEM.](nihms952316f1){#F1}

![Intrauterine inflammation leads to decreased total neuronal density and transient migration abnormalities in the dentate gyrus. Quantification of granule cell density in the granule cell layer (GCL) (A), granule cell layer thickness (B), and ectopic granule cell density in the hilus (C) at postnatal days 14 and 28. \*p \< 0.05. Data represent the mean ± SEM. (D) Confocal maximum projection images of the granule cell-specific marker Prospero Homeobox 1 (Prox1) in the dentate gyrus of mice exposed to intrauterine saline or lypopolysaccharide (LPS) and sacrificed at P14 (LPS: n = 10; saline: n = 8). Dotted lines depict the granule cell layer (GCL)/hilar border. High magnification images depicted on the bottom left were taken from the center of the hilus. Scale bar = 100 μm, magnified panel = 10 μm.](nihms952316f2){#F2}

![Intrauterine inflammation has no effect on the number and division rate of neuronal progenitor cells. Confocal maximum projection images of Nestin (A, yellow) and Ki67 (C, yellow) labeling of the neural progenitor cells in the dentate gyrus of mice exposed to intrauterine saline or lipopolysaccharide (LPS) and sacrificed at postnatal day 14 (P14). Arrows depict Nestin-positive neuronal progenitor cells in the subgranular zone (A). Cell nuclei are counterstained with 4′,6-diamidino-2-phenylindole (DAPI, blue). Scale bars are 20 μm (A) and 100 μm (C). Quantification of neuronal progenitor cell density (B) and the density of the Ki67 labeled cells (D) in the subgranular zone at P14 and P28. Data represent the mean ± SEM. P14: LPS, n = 10; saline, n = 8; P28: LPS n = 6; saline n = 6.](nihms952316f3){#F3}

![Intrauterine inflammation has no effect on postnatal apoptosis in the dentate gyrus. (A) Confocal maximum projection images through the dentate gyrus of mice exposed to intrauterine saline or lipopolysaccharide (LPS) and sacrificed at postnatal day 14 (P14). Apoptotic cells are labeled with antibodies against Cleaved Caspase-3 (yellow). 4′,6-diamidino-2-phenylindole (DAPI, blue) labels cell nuclei. Scale bar = 20 μm. (B) Quantification of Cleaved Caspase-3-expressing cells in the granule cell layer of the dentate gyrus at P14 and P28. Data represent the mean ± SEM. P14: LPS, n = 10; saline, n = 8; P28: LPS n = 6; saline n = 6.](nihms952316f4){#F4}

![Intrauterine inflammation has no effect on hippocampal microglia density. (A) Confocal maximum projection images of the microglia-specific marker Ionized calcium-binding adapter molecule 1 (Iba1, green) in the Cornu Ammonis 1 (CA1) hippocampal region of mice exposed to intrauterine saline or lipopolysaccharide (LPS) and sacrificed at postnatal day 28 (P28). 4′,6-diamidino-2-phenylindole (DAPI) counterstains cell nuclei (blue). Scale bar = 100 μm. (B) Quantification of microglia density in the dentate gyrus, hilus, CA1, and CA2-3 regions at P14. Data represent the mean ± SEM. P14: LPS, n = 10; saline, n = 8; P28: LPS n = 6; saline n = 6.](nihms952316f5){#F5}

![Intrauterine inflammation has no effect on hippocampal astrocyte density. (A) Confocal maximum projection images of the astrocyte-specific marker Glial Fibrillary Acidic Protein (GFAP, red) in the Cornu Ammonis 1 (CA1) hippocampal region of mice exposed to intrauterine saline or lipopolysaccharide (LPS) and sacrificed at postnatal day (P14). Cell nuclei are labeled with 4′,6-diamidino-2-phenylindole (DAPI) counterstain (blue). Scale bar = 100 μm. (B) Quantification of astrocyte density in the dentate gyrus, hilus, CA1, and CA2-3 regions at P14. Data represent the mean ± SEM. P14: LPS, n = 10; saline, n = 8.](nihms952316f6){#F6}
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